Salt Lake City, UT (September 8, 2022) Chief Scientist Dr. David Vollmer announced that Cosmetics magazine has accepted the 4Life äKwä Skincare System.® clinical study for publication.
The 4Life clinical study will appear in a special issue of Cosmetics: Novel Cosmetic Ingredients, Formulations and Devices.
Dr. Lowry Khan, Vice President of Product Development said: “This Cosmetics and its research has appeared in an authoritative magazine. This journal publishes data in the field of cosmetic science and technology. This fact marks our first published clinical study of 4Life skin care products. And represents another step in our ongoing effort to scientifically validate all 4Life products.”
A clinical study evaluated the effectiveness of the 4Life äKwä Skin Care System in improving facial health and beauty.
Twenty-six healthy adult women and men, aged 18-54, participated in the cosmetic study. We took participants with different skin types and skin tones. There were two groups in the study: 1 – active, using our cosmetics, 2 – control. Deadline: 30 days.
Eventually.
Senior Vice President of Marketing Kelly Bellerose said: “Dry skin, fine lines, fine lines, red spots, and red vascularity on the face are gone. This indicates a large amount of porphyrin saturated with skin tumors. These are general indicators of the health and beauty of the skin. In this study, our subjects noted that the äKwä Skincare System cosmetics significantly improved skin moisture, many red spots disappeared and the number of red blood vessels decreased. There was a large amount of porphyrin in the skin compared to the control group.”https://transferfactor.hu/en/akwa-skin-care-system/
- 4Life, the Immune System Company™, and the first to bring transfer factor research to market, has offices in 25 markets to serve the company’s worldwide customers.
- For more information:
Calvin Jolley
Vice President
Corporate Communications
